Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies

Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies

ACPA, anti-citrullinated protein/peptide antibodies; ACR, American College of Rheumatology; DAS28, 28-joint Disease Activity Score; DMARD, disease-modifying antirheumatic drug; EULAR, European League Against Rheumatism; HAQ, Health Assessment Questionnaire; TNF, tumour necrosis factor.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2009-06, Vol.68 (6), p.1075-1077
Hauptverfasser: Teng, Y K O, Tekstra, J, Breedveld, F C, Lafeber, F, Bijlsma, J W J, van Laar, Jacob M
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal - administration & dosage
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents - administration & dosage
Antirheumatic Agents - therapeutic use
Arthritis, Rheumatoid - drug therapy
Arthritis, Rheumatoid - immunology
B-Lymphocytes - immunology
Biological and medical sciences
Diseases of the osteoarticular system
Drug Administration Schedule
Female
Follow-Up Studies
Gangrene
Humans
Immunomodulators
Inflammatory joint diseases
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Prospective Studies
Rheumatism
Rheumatoid arthritis
Rheumatology
Rituximab
Studies
Tumor necrosis factor-TNF
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ACPA, anti-citrullinated protein/peptide antibodies; ACR, American College of Rheumatology; DAS28, 28-joint Disease Activity Score; DMARD, disease-modifying antirheumatic drug; EULAR, European League Against Rheumatism; HAQ, Health Assessment Questionnaire; TNF, tumour necrosis factor.
ISSN:0003-4967
1468-2060
DOI:10.1136/ard.2008.100438